Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HP INC Director's Dealing 2022

Dec 13, 2022

30213_dirs_2022-12-12_0ce7a258-cc96-4f58-821f-99a99559d1ec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HP INC (HPQ)
CIK: 0000047217
Period of Report: 2022-12-08

Reporting Person: Jacobs Julie M (Chief Legal Officer and GC)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-12-08 Restricted Stock Units $ A 49157 Acquired Common Stock (49157) Direct
2022-12-08 Performance Adjusted Restricted Stock Units $ A 31449 Acquired Common Stock (31449) Direct
2022-12-08 Performance Contingent Stock Options $28.48 A 111316 Acquired 2032-12-08 Common Stock (111316) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2: On 12/8/2022, the reporting person was granted 49,157 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F3: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock.

F4: On 12/8/2022, the reporting person was granted 31,449 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F5: On 12/8/2022, the reporting person was granted 111,316 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.